The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Therios 300 mg palatable tablets for dogs



Ceva Santé AnimaleVPA10815/033/002

Main Information

Trade NameTherios 300 mg palatable tablets for dogs
Active SubstancesCefalexin monohydrate
Dosage FormTablet
Licence HolderCeva Santé Animale
License Holder Address10, avenue de La Ballastière
33500 Libourne
France
Licence NumberVPA10815/033/002

Group Information

ATC CodeQJ01DB01 cefalexin
Therapeutic ClassAntibacterial
SpeciesDogs

Status

License statusAuthorised
Licence Issued16/04/2010
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back